These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 1771591)
21. Quantifying Proximal Collecting Tubule Deficiency in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Fetopathy. Saunders J; Callejas Salgado AM; Ting JY; Mammen C; Terry J; Bush JW Pediatr Dev Pathol; 2021; 24(5):438-444. PubMed ID: 34082612 [TBL] [Abstract][Full Text] [Related]
22. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus? Yip SK; Leung TN; Fung HY Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182 [No Abstract] [Full Text] [Related]
23. Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant. Bass JK; Faix RG Am J Perinatol; 2006 Jul; 23(5):313-7. PubMed ID: 16799914 [TBL] [Abstract][Full Text] [Related]
25. [Toxicity of levorin to pregnant rats and their fetus]. Slonitskaia NN Antibiotiki; 1970 Dec; 15(12):1089-93. PubMed ID: 4322740 [No Abstract] [Full Text] [Related]
26. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations]. Lonati C; Morganti A Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495 [No Abstract] [Full Text] [Related]
27. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Schaefer C Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309 [TBL] [Abstract][Full Text] [Related]
28. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report]. Sadeck LS; Fernandes M; Silva SM; Trindade AA; Chia CY; Ramos JL; Leone CR Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(6):328-32. PubMed ID: 9629744 [TBL] [Abstract][Full Text] [Related]
29. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Hanssens M; Keirse MJ; Vankelecom F; Van Assche FA Obstet Gynecol; 1991 Jul; 78(1):128-35. PubMed ID: 2047053 [TBL] [Abstract][Full Text] [Related]
30. [Angiotensin-converting enzyme inhibitors. Principles and rules of use]. Eicher JC; Wolf JE Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373 [No Abstract] [Full Text] [Related]
31. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations]. de Leeuw PW Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062 [TBL] [Abstract][Full Text] [Related]
32. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors. Cooper WO J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502 [TBL] [Abstract][Full Text] [Related]